That is very important, due to the fact that the method a protein in the body folds determines if a pharmaceutical will be able to bind to that protein and be efficient. To put it simply, we have to know how these proteins fold if we want a drug to work. Historically, this has actually been a trial-and-error process (legacy report prediction). Now, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're designed to do. This was a development practically no one observed. However it's going to have extensive implications for curing disease. I predict that Alpha, Fold will be 98% precise by the end of 2021.
And, of course, there will be lots of financial investment chances in this area, too. Moving topics It's going to be a good year for bitcoin. I'm bullish on it in 2021 (tech predictions). That said, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I would not be amazed if it pulled back maybe significantly before going greater - last week. I have actually been covering bitcoin for a very long time now. One of the first research study reports I ever published was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial recommendation, I entitled my report "What's the Big Offer With Bitcoin?" That reveals you where the discussion was at the time. We were mainly educating readers. However that's not the huge question anymore. Now we're seeing institutional money finally take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, niche enterprise. Mass, Mutual is a trusted 170-year-old institution. So believe about that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a big reason I'm bullish on it this year. jeff brown predictions for 2021. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus prediction 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These companies raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I forecast 2021 will be another record year in IPOs. There are numerous terrific personal business on the brink of hitting the general public markets And I've been working on a new way for you to invest even before these business go public.
This chance has actually been building over the last couple of years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to find out all the information. Go right here to book your spot for free.
Emma Walsh here, managing editor of the Journal. Routine Journal readers know that tech isn't our normal beat (legacy report prediction). And when it concerns tech investing, we leave it to the professionals. The good news is, we have several such experts in our Rolodex. Our associate Jeff Brown will be familiar to our long time readers. He is one of the most accomplished tech investing professionals we understand (future report review). In reality, he had numerous triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take an appearance at the huge photo and anticipate what's just around the corner.
That includes things like 5G networks, biotech, expert system, and a lot more. These patterns are experiencing rapid development and producing incredible opportunities for investors. I desire to make sure all our readers are gotten ready for what's next. And with that in mind, let me draw the photo of what I see coming in the next 12 months Our new 5G (fifth-generation) cordless networks are a topic I have actually been covering for years now. jeff brown genetic sequencer stock. But regardless of what lots of readers might believe, this is a trend that's just getting going. Although the COVID-19 pandemic disrupted supply chains in 2015, an excellent 250 million 5G-enabled devices were still sold.
And all of this eventually caused Apple delaying the release of the 5G-enabled i, Phone 12 by 2 months (bleeding edge). Losing two months of production and sales truly impacts how lots of 5G devices are offered in the fiscal year. When you consider all of that, offering 250 million systems is exceptional. More notably, the hold-ups triggered by the pandemic produced a lot of pent-up need. And that demand is now going to be pressed into 2021. In reality, I forecast that more than 500 million 5G devices will be delivered in 2021 - future report review. Which's not my only 5G forecast When I have actually discussed 5G in the past, I have actually described its 3 various stages.
In Phase Two, 5G gadgets go on sale. 5G phones and other products begin to reach consumers. And in Phase Three, 5G services start to be offered (first lady). That's when we begin to see applications operating on 5G networks. Believe of things like massive multiplayer video games over a smart phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G prediction for 2021 is that we will start Phase Three by this summer. This begins something of a virtuous cycle: A lot of people do not really care about the technology. But they will care if there are interesting applications that can only be accessed with a 5G phone.
That causes more 5G apps being developed. In reality, 5G is going to open a suite of amazing applications: self-driving vehicles, the Internet of Things, robotic surgery, and more. All of these innovations require 5G. The financial investment opportunities going forward will be massive. Stepping far from 5G, the next essential technology I visualize in 2021 is CRISPR hereditary modifying. CRISPR stands for "clustered regularly interspaced short palindromic repeat." It's a mouthful. But it's one of the most exciting developments in biotechnology. At a high level, CRISPR is an innovation that can edit our hereditary makeup as if it were software application.
The program can crash or not operate correctly. CRISPR uses a similar concept however with our hereditary code. "Typos" in our genome can cause illness. CRISPR can fix these "typos." For several years, CRISPR was mainly a niche technology that wasn't well comprehended. And during that time, there were truly just 3 companies running in this space. However things are changing. CRISPR is no longer just theoretical. We're seeing real outcomes. We're dealing with illness and seeing that this innovation simply works. And as a result, a "2nd crop" of early-stage CRISPR business is going public and delivering extraordinary returns. This entire market is effectively a greenfield chance.
There's room for numerous business to exist in this area. jeff brown stock predictions 2021. And there will be more. That's my forecast for CRISPR in 2021. I forecast that two or 3 more genetic modifying companies will hold their IPOs. Sticking to biotechnology, we are seeing incredible things occurring at the convergence of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its newest Alpha, Fold software can properly predict the folding of a protein based exclusively on its amino acid series with 92. 4% precision. That is essential because the way a protein in the body folds determines if a pharmaceutical will be able to bind to that protein and be efficient.
Historically, this has been a trial-and-error procedure. Now, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it much simpler to develop drugs that do what they're created to do. And here's my next prediction. I forecast that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one however a number of drug treatments produced utilizing this technology. This was one of those breakthroughs that almost no one saw. But it's going to have extensive implications for treating illness. And, obviously, there will be plenty of investment chances in this area, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That said, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be amazed if it pulled back perhaps substantially prior to going higher. I've been covering bitcoin for a very long time now. Among the first research study reports I ever published was on bitcoin - brownstone research. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on investment for anybody who followed my suggestion. However at the time of that initial suggestion, I titled my report, "What's the Big Deal With Bitcoin?" That shows you where the conversation was at the time.
But no one is asking that question anymore. Now, we're seeing institutional cash finally taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche enterprise. last year. Mass, Mutual is a 150-year-old institution. So think of that. In 5 years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more bonus forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and declares the information is up to date since February 2021, but we could not separately confirm this claim. Given Jeff Brown's past, he likely has a significant net worth, however we can't hammer down an exact figure at this minute. Brown is best understood for his sage-like capability to choose winning innovation stocks. He spent more than 25 years looking into technology business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience gives him an exceptional perspective on the marketplace. He's constantly on the hunt for new opportunities, and he shares much of his finest picks in the Future Report.
That's high praise, however it's not ridiculously reasoned. Brown has an exceptional credibility as a stock-picker, and he successfully predicted a few of the greatest economic occasions of the previous twenty years. Although he does not appear to release his choices to the general public, the service's success is a direct indicator of Brown's stock-picking expertise. Nobody on Wall Street gets it ideal whenever, however Jeff Brown's accurate forecasts have actually earned him legions of devoted followers. That states a lot about his capability. The Near Future Report is released by Brownstone Research study, a popular financial research publisher. Brownstone Research offers several research study services with a wide variety of expertises - jeff brown prediction.
The business is also associated with Bonner & Partners, another well-respected research publisher - last year. On its site, Brownstone states its mission is to offer retail investors with professional-grade research: "For too long, the very best financial investment research study has not been offered to private investors. It has been normally scheduled for financial investment banks, hedge funds, personal equity, and high-net-worth clients. future report review. The objective of Brownstone Research study is to make that type of proprietary research available to any financiers wanting to acquire an edge in the markets. The objective is basic to provide special and successful financial investment research found nowhere else." -Brownstone Research site excerpt from the Jeff Brown is the founder of Brownstone Research, and he likewise acts as the company's Chief Financial investment Expert.
With Brown directing the ship, Brownstone Research is a powerhouse publisher with lots to use its customers. After decades of stable success at the helm of top-tier business like Tesla and Space, X, Elon Musk is a family name throughout the majority of America. If you understand even a bit about the marketplace, you know that he has a track record as a King Midas of sorts. self-driving cars. Whatever he touches turns to gold! Jeff is well conscious of Elon Musk's executive prowess, so he constantly has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big job.
In truth, Brown believes S.A.V. biotech stocks jeff brown. could be "the greatest pattern of the 2020s, and he's not alone. Examine out these quotes from other widely known S.A.V. bulls: Elon's next huge act will be weding two cutting-edge technologies: artificial intelligence and electrical cars. Musk hopes the mix will help him establish the first fully-autonomous, self-driving automobiles ever. It's absolutely nothing short of the automobile market's Holy Grail. As you know, electrical automobiles and self-driving automobile stocks have actually been huge this year, however the Wall Street machine has been huge on buzz without much concrete outcome. Regardless of an extreme boost in competition over the past few years, Brown still believes Musk has the very best possibility of putting all of it together.
tech might be the magic string that ties all of it together. S.A.V. stands for Shared Autonomous Vehicle, and it could be the future of transport. Generally, this technology would permit you to rent out your cars and truck as an autonomous, self-driving taxi when you're not using it. You just leave the cars and truck and press a button on an app that informs the cars and truck to "join the fleet." Next thing you understand, you're unwinding on your sofa while your car shuttles ride-sharers around town. Most importantly, you get to keep a hefty portion of the profits. It sounds outrageous, but it might be closed than you think.